Dean Y Li - Net Worth and Insider Trading
Dean Y Li Net Worth
The estimated net worth of Dean Y Li is at least $30 Million dollars as of 2023-09-23. Dean Y Li is the Director of Recursion Pharmaceuticals Inc and owns about 3,784,311 shares of Recursion Pharmaceuticals Inc (RXRX) stock worth over $30 Million. Details can be seen in Dean Y Li's Latest Holdings Summary section.
Transaction Summary of Dean Y Li
Dean Y Li Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dean Y Li owns 3 companies in total, including Merck & Co Inc (MRK) , Recursion Pharmaceuticals Inc (RXRX) , and Merck & Co Inc (MRKPRB.PFD) .
Click here to see the complete history of Dean Y Li’s form 4 insider trades.
Insider Ownership Summary of Dean Y Li
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MRK | Merck & Co Inc | 2021-01-01 | Executive VP & President & MRL |
| RXRX | Recursion Pharmaceuticals Inc | 2021-04-15 | director |
| MRKPRB.PFD | Merck & Co Inc | 2021-01-01 | Executive VP & President & MRL |
Dean Y Li Latest Holdings Summary
Dean Y Li currently owns a total of 1 stock. Dean Y Li owns 3,784,311 shares of Recursion Pharmaceuticals Inc (RXRX) as of December 7, 2021, with a value of $30 Million.
Latest Holdings of Dean Y Li
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| RXRX | Recursion Pharmaceuticals Inc | 2021-12-07 | 3,784,311 | 7.92 | 29,971,743 |
Holding Weightings of Dean Y Li
Dean Y Li Form 4 Trading Tracker
According to the SEC Form 4 filings, Dean Y Li has made a total of 3 transactions in Recursion Pharmaceuticals Inc (RXRX) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Recursion Pharmaceuticals Inc is the sale of 15,900 shares on December 7, 2021, which brought Dean Y Li around $325,632.
Insider Trading History of Dean Y Li
- 1
Dean Y Li Trading Performance
Dean Y Li Ownership Network
Ownership Network List of Dean Y Li
Ownership Network Relation of Dean Y Li
Dean Y Li Owned Company Details
What does Merck & Co Inc do?
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.
Who are the key executives at Merck & Co Inc?
Dean Y Li is the Executive VP & President & MRL of Merck & Co Inc. Other key executives at Merck & Co Inc include President & Human Health Int?l Joseph Romanelli , Chief Marketing Officer Chirfi Guindo , and SVP Human Health Global Mktg. Arpa Garay .
Merck & Co Inc (MRK) Insider Trades Summary
Over the past 18 months, Dean Y Li made no insider transaction in Merck & Co Inc (MRK). Other recent insider transactions involving Merck & Co Inc (MRK) include a net sale of 133,401 shares made by Steven Mizell , a net sale of 2,172,853 shares made by Kenneth C Frazier , and a net sale of 4,715 shares made by Joseph Romanelli .
In summary, during the past 3 months, insiders sold 8,839 shares of Merck & Co Inc (MRK) in total and bought 0 shares, with a net sale of 8,839 shares. During the past 18 months, 3,613,019 shares of Merck & Co Inc (MRK) were sold and 409 shares were bought by its insiders, resulting in a net sale of 3,612,610 shares.
Merck & Co Inc (MRK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Merck & Co Inc Insider Transactions
Dean Y Li Mailing Address
Above is the net worth, insider trading, and ownership report for Dean Y Li. You might contact Dean Y Li via mailing address: 2000 Galloping Hill Road, Kenilworth Nj 07033.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
